Cargando…
Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a major cause of death among patients with liver cirrhosis. The rise of immuno‐oncology has revolutionized treatment for advanced HCC. However, most pivotal randomized controlled trials have excluded patients with moderate liver dysfunction (Child–Pugh–Turcotte B),...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358256/ https://www.ncbi.nlm.nih.gov/pubmed/37162288 http://dx.doi.org/10.1002/cam4.6033 |